A Closer Look: Methamphetamine, Opioids and Poly-Substance Use
The purpose of this training is to explore the intersection of methamphetamine, opioids and poly-substance use. Methamphetamine use has increased significantly in Iowa in recent years, and opioid and poly-substance use continue to be prevalent. This issue results in significant need for increased training on these topics to professionals serving those affected by substance use.
“A Closer Look: Methamphetamine, Opioids and Poly-substance Use” is a part of the Iowa Department of Public Health’s initiatives that support substance use prevention, treatment and recovery. For more information on IDPH’s initiatives, please visit YourLifeIowa.org.
Community service providers and health professionals who would benefit from behavioral health education.
- Identify recent data trends that explain the complex presentation and effective prevention and treatment of poly-substance use.
- Identify local resources in the state of Iowa for accessing prevention and treatment services.
- Identify the evidence and research that explains the impact on special populations affected by poly-substance use.
Problems with drug use can affect people from many backgrounds. They can be rich or poor, of any age, and any gender. Problems with substance use can affect people of every race and religion, regardless of income or education levels.
From 2014-2017, there was a 38 percent increase in methamphetamine treatment admissions in Iowa. Similarly, the Iowa Department of Public Health (IDPH) reports there was an eight-fold increase in Iowa deaths related to amphetamines, which includes methamphetamine.
“Meth is now the second most reported drug by adults at admission to treatment, moving ahead of marijuana for the first time. Alcohol remains number one for adults, while marijuana remains the number one drug of choice for juveniles,” said Katie Bee of the IDPH Bureau of Substance Abuse. “It is important for Iowans to know help is available from Iowa’s treatment network, which can be found at yourlifeiowa.org.”
Methamphetamine is a highly addictive stimulant and is most commonly a white, odorless powder. In the short term, its effects include increased attention and activity, decreased appetite and a rapid heartbeat. In the long term, consequences include paranoia, hallucinations, brain structure changes, memory loss, aggression and severe dental problems.
In 2017, there were 206 overdose deaths involving opioids in Iowa—a rate of 6.9 deaths per 100,000 persons compared to the average national rate of 14.6 deaths per 100,000 persons. The greatest rise occurred among heroin-involved deaths (Figure 1), which more than quadrupled from 14 deaths in 2012 to 61 deaths in 2017. Deaths involving synthetic opioids other than methadone (mainly fentanyl), rose threefold from 29 cases in 2011 to 92 cases in 2017. Since 1999, prescription opioid-involved deaths steadily rose to a peak of 132 in 2012, but since then, they have declined by 20 percent to 104 cases in 2017. In 2017, Iowa providers wrote 56.4 opioid prescriptions for every 100 persons.
|8:15 am||Registration and Breakfast|
|9 am||Speeding Through Time: Historical Trends of Stimulant and Opioid Use Disorder Epidemics in the United States|
Jim Hall, PhD, Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University
|10:45 am||Heroin, Meth, and Poly-Substance Abuse: Where We Are Now|
Jane Carlisle Maxwell, PhD, Center for Social Work and Research, University of Texas at Austin
|1:15 pm||Treatment of Opioid Use Disorder and Polysubstance Use Disorder in Primary Care|
Nicole Gastala, MD, Family Medicine, University of Illinois Health and Mile Square
|2:45 pm||Gambling, Opioid and Stimulant Use Disorders: Intersections and Integration|
Loreen Rugle, PhD, ICGC-II/BACC, Department of Psychiatry, University of Maryland
Nicole Gastala, MD is a member of the National Health Service Corp and has practiced full spectrum outpatient family medicine in both rural and urban settings. As the opioid epidemic began to hit Iowa, it became acutely necessary to expand and develop a team-based community program to address substance use disorder. Through a HRSA grant funded Medication for Opioid Use Disorder (MOUD) program at Primary Health Care, Inc, their team developed an effective integrated treatment model. Dr. Gastala was awarded the Certificate of Public Health Recognition for Addressing the Opioid Crisis in Iowa by the Iowa Department of Public Health in 2018. As she has transitioned to her position as Director of Behavioral Health and Addiction at University of Illinois Chicago/UI Health Mile Square Health Centers, Dr. Gastala has continued to work to develop an integrated MOUD program by mentoring new prescribers, precepting residents, and training clinicians within the Chicago community and increasing access to MOUD nationally as a mentor and trainer. She is currently a hub panel expert of a bimonthly ECHO webinar focused on MAT in primary care for Iowa and Illinois as well as the Implementation Subcommittee Chair of the Illinois Opioid Crisis Advisory Council. Dr. Gastala is currently a Co-Investigator on an Arnold Venture-funded project that aims to develop and test a syringe service-based approach for linking clients to MOUD.
Jane Carlisle Maxwell, PhD is a Research Professor with the Addiction Research Institute at the School of Social Work, University of Texas at Austin. She has been a member of the SAMHSA National Advisory Council, a consultant to the the Food and Drug Administration and Centers for Disease Control, a Fulbright Senior Specialist, and along with Jim Hall, a member of the National Institute on Drug Abuse's Community Epidemiology Work Group and NIDA’s National Drug Early Warning System. She has over 50 years experience monitoring changes in drug use patterns in Texas, in the U.S., and Internationally. She is a member of the College on Problems of Drug Dependence and serves on the board of the Pacific Institute on Research and Evaluation.
Jim Hall, PhD has recently retired as Senior Epidemiologist with the Center for Applied Research on Substance Use and Health Disparities at Nova Southeastern University. For the past 35 years, he has tracked patterns and trends of drug use in Florida for the National Institute on Drug Abuse. Hall has testified before the US Senate Committee on the Judiciary about fentanyl analogues and other Novel Psychoactive Substances. Jim serves on the Scientific Advisory Panel of the National Institutes of Health’s National Drug Early Warning System and the US Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee. He was presented with a Lifetime Achievement Award by the Florida Alcohol and Drug Abuse Association in 2017.
Loreen Rugle, PhD, ICGC-II/BACC brings 35 years of experience in the field of problem and responsible gambling including treatment, prevention, research and responsible gambling to her current positions. She has managed problem gambling programs within the Veterans Administration, in the private sector and within state systems. She has participated in research on brief screening for gambling problems, as well as a broad range of other problem gambling related research projects. She has provided consultation and training on gambling disorder throughout the United States, for the military and internationally. She is Assistant Professor in the Department of Psychiatry, University of Maryland and Special Projects Consultant with the Maryland Center of Excellence on Problem Gambling. She is also currently Responsible Gambling Specialist with the North American Association of State and Provincial Lotteries.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Katie Bee, CPS, Planning Committee Member
- Jane Carlisle Maxwell, PhD, Speaker
- Jim Hall, PhD, Speaker
- Jennifer Robertson-Hill, LMHC, Planning Committee Member
- Loreen Rugle, PhD, ICGC-II/BACC, Speaker
- Michele Tilotta, MPA, BSN, RN, Planning Committee Member
- Cara Weis, MPA, Activity Director and Planning Committee Member
- Monica Wilke-Brown, LMHC, Planning Committee Member
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.
- Nicole Gastala, MD, Speaker - No financial relationships to disclose but does intend to discuss off-label uses of commercial products/devices.
From Interstate 235 W
Take the 50th St exit, EXIT 1A, toward West Des Moines. Turn right onto 50th St. Take the first left onto Westown Parkway. Turn left onto West Lakes Parkway. This will take you to The Ron Pearson Center parking lot.
From Interstate 80 E
Take the 60th St exit, EXIT 122, toward West Des Moines. Turn left onto 60th St. Turn right onto Westown Parkway. Turn right onto West Lakes Parkway. This will take you to The Ron Pearson Center parking lot.
From Interstate 35 N
Take the University Ave exit, EXIT 72C, toward Clive. Turn left onto University Ave. Go left onto West Lakes Parkway. This will take you to The Ron Pearson Center parking lot.
From Interstate 35 S
Take the University Ave exit, EXIT 124, toward Clive. Turn right onto University Ave. Go left onto West Lakes Parkway. This will take you to The Ron Pearson Center parking lot.
A block of 20 rooms has been reserved at the Hampton Inn & Suites West Des Moines. The discounted rate is $99 plus tax per room and includes a complimentary hot breakfast. Parking is also complimentary onsite.
Hampton Inn & Suites West Des Moines
6160 Mills Civic Parkway
West Des Moines, IA 50266
Mention the block “IDPH” to book at the special discounted rate or use the online booking link.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Department of Public Health. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 5.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 5.5 continuing education contact hour(s). No partial credit awarded.
- DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this live activity for a maximum of 5.5 continuing education contact hour(s).
- Pharmacy: Approved for 5.5 CPE contact hours. CEI is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN: 0107-9999-19-355-L01-P | 0.55 CEUs/5.5 Hrs. 0107-9999-19-355-L01-T | 0.55 CEUs/5.5 Hrs. Participants will be required to logon to the CEImpact Learning Management System (LMS) within 30 days to claim their credit. Visit the event website for instructions.
- Substance Abuse: Approved by Iowa Board of Certification for up to 5.75 Alcohol and Drug Specific contact hours.
- Behavioral Health Professionals: Certificates of Completion will be provided to indicate 5.75 contact hours. It is the licensees’ responsibility to determine if the continuing education programs they attend meet the requirements of their professional licensure board.
- Other Healthcare Providers: This live activity is designated for 5.5 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
“A Closer Look: Methamphetamine, Opioids and Poly-substance Use” is funded by the State Opioid Response (CFDA 93.788) federal grant, a Substance Abuse Mental Health Services administration grant and the Iowa Gambling Treatment Program.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
The information shared at this event is presented as an opportunity to expand awareness and knowledge. Views expressed by speakers do not represent the views of the Iowa Department of Public Health, nor does IDPH control or guarantee the accuracy of this information. IDPH does not endorse individual exhibitors, products or services. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
- 5.50 AMA PRA Category 1 Credits™
- 5.50 AOA Category 2A
- 5.50 CE Contact Hour(s)
- 5.50 CPME
- 5.50 IBON
The registration fee is $25. Light refreshments, lunch and continuing education credits are included in the registration fee.
There will be no refunds for the event, you may send a substitute.
For questions about your registration
Iowa State University
1601 Golden Aspen Drive, Suite 110
Ames, IA 50010
For questions about program content
PPW & POMW Project Director
Iowa Department of Public Health | Division of Behavioral Health